News
Modeling CRISPR/Cas operations with phage strategy
Tuesday, 25 February 2025 17:27Research teams from Würzburg and Braunschweig have discovered a novel mechanism of a protein that counteracts the CRISPR/Cas process. It can be used to specifically control CRISPR technologies.
Jena: Multiorgan-on-a-Chip to predict drug effects in pregnant women
Tuesday, 25 February 2025 15:18The organ-on-a-chip developer Dynamic42 from Jena, ESQlabs, experts in digital solutions for life sciences, in close collaboration with Bayer's Consumer Health Division and the placental laboratory of the University Hospital Jena have successfully developed a three-organ system. The model has the potential to significantly reduce animal testing using organ-on-chip (OoC) technology and interactive computer software.
Adiposetissue.org: platform to study metabolic diseases
Tuesday, 25 February 2025 12:05A European research team has developed an adipose tissue portal with molecular and clinical data from more than 6,000 women and men from 67 studies. The researchers want to facilitate research into obesity and metabolic diseases by centralizing and simplifying access to data on adipose tissue.
New funding guideline “Application of Artificial Intelligence (AI) in drug research”
Thursday, 20 February 2025 13:56With this funding measure, the BMBF (Federal Ministry of Education and Research) is pursuing the goal of implementing the process of drug research faster and with a higher success rate in the future along the entire development chain using AI.
Basic research: Watching the ageing process of the brain in vitro
Thursday, 20 February 2025 10:45Prof. Frank Edenhofer, head of the Genomics, Stem Cell Biology and Regenerative Medicine research group at the University of Innsbruck, and his team have developed a human tissue model that can be used to watch the brain aging process.
JRC standardizes organ-on-a-chip technology
Wednesday, 19 February 2025 17:24The aim of standardization is to ensure that organ-on-a-chip devices can be used reliably and effectively for the development of new drugs, in personalized medicine and for safety testing of chemicals and consumer products such as cosmetics.
Education: ECVAM presents virtual laboratory for school children
Tuesday, 18 February 2025 15:03The European Union Reference Laboratory for alternatives to animal testing (ECVAM) has presented a virtual laboratory developed for pupils aged between 14 and 18, but also for older school children. In a 20-minute film, a professor guides the "students" through research into a new alternative to animal testing.
ECVAM offers access to its laboratories
Tuesday, 18 February 2025 14:37The European Validation Authority EURL ECVAM offers users open access to its High-Throughput Testing laboratory.
Applied research in vitro: suitability of ASOs for therapy in rare diseases proven
Monday, 17 February 2025 16:01Using heart organoids, researchers from the Genomic Medicine Center and Children's Mercy Research Institute, the University of Missouri-Kansas City School of Medicine and the University of Kansas Medical Center in Kansas City have demonstrated the efficacy of their antisense oligonucleotides in patients.
Basic research in vitro: environmental factors can influence brain development
Monday, 17 February 2025 14:13What specifically happens when developing nerve cells are exposed to “chronic” stress has been investigated by researchers at the Max Planck Institute of Psychiatry in Munich using cell models of the developing brain.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.